Tumor-specific methylation of the 8p22 tumor suppressor gene DLC1 is an epigenetic biomarker for Hodgkin, nasal NK/T-cell and other types of lymphomas.
about
DLC1 is a chromosome 8p tumor suppressor whose loss promotes hepatocellular carcinomaTranscriptional induction of DLC-1 gene through Sp1 sites by histone deacetylase inhibitors in gastric cancer cellsLow expression of DLC1 is predictive of poor therapeutic efficiency of fluoropyrimidine and oxaliplatin as adjuvant chemotherapy in gastric cancerDLC1 tumor suppressor gene inhibits migration and invasion of multiple myeloma cells through RhoA GTPase pathwayCancer genes hypermethylated in human embryonic stem cells.Colorectal cancer DNA methylation marker panel validated with high performance in Non-Hodgkin lymphomaIdentification of highly methylated genes across various types of B-cell non-hodgkin lymphoma.Genomic imbalances in esophageal carcinoma cell lines involve Wnt pathway genesAn improved sequencing-based strategy to estimate locus-specific DNA methylation.Epigenetic silencing of the 3p22 tumor suppressor DLEC1 by promoter CpG methylation in non-Hodgkin and Hodgkin lymphomas.Curcumin inhibits growth of human breast cancer cells through demethylation of DLC1 promoter.Deleted in liver cancer 1 (DLC1) utilizes a novel binding site for Tensin2 PTB domain interaction and is required for tumor-suppressive function.Frequent concomitant epigenetic silencing of the stress-responsive tumor suppressor gene CADM1, and its interacting partner DAL-1 in nasal NK/T-cell lymphoma.CpG island methylator phenotype and its relationship with prognosis in adult acute leukemia patients.Hypermethylation of PRDM1/Blimp-1 promoter in extranodal NK/T-cell lymphoma, nasal type: an evidence of predominant role in its downregulation.DLC1 expression is reduced in human cutaneous melanoma and correlates with patient survival.
P2860
Q28384558-AF17B718-6F57-481D-85EF-42793C1DC0CEQ28388574-CAD4BA39-4F24-4067-8E3A-DFAE471AC039Q28389464-319FD628-A1FF-47B4-AA90-A7E677BBE313Q28392462-DA55D5E3-DCB5-4C1A-ACC2-89AD7522E4FCQ33372334-2B47E51D-81C5-4A8B-899D-ABC0803FC871Q33740695-FF75601D-911B-4E4A-AE02-997E110D8E34Q35048563-E4BA0778-7359-4724-A6FE-50D43F3A7BC3Q35085978-B2665517-F090-4FFB-A468-DFB8AD5C80C1Q35782282-948F2077-E5F5-4434-AFE2-9B1C4F291381Q36517724-AA39247D-C122-47B6-A279-0B98094C5B69Q38731988-02A9AC4A-143E-44C7-87BB-E933D7D1CED1Q39851862-3D8EC9C7-C81F-42A6-BE5B-4E46579DB385Q39900606-E9C8C58F-9154-4359-B4C6-F460EAC34A15Q43649407-B9E8ED83-9771-457E-B17D-012875023B61Q52845594-E9692743-41A2-456B-B7AB-B09EFBBB7347Q53099758-C4E0A38D-7AED-4567-894E-26C030B20314
P2860
Tumor-specific methylation of the 8p22 tumor suppressor gene DLC1 is an epigenetic biomarker for Hodgkin, nasal NK/T-cell and other types of lymphomas.
description
2007 nî lūn-bûn
@nan
2007年の論文
@ja
2007年論文
@yue
2007年論文
@zh-hant
2007年論文
@zh-hk
2007年論文
@zh-mo
2007年論文
@zh-tw
2007年论文
@wuu
2007年论文
@zh
2007年论文
@zh-cn
name
Tumor-specific methylation of ...... and other types of lymphomas.
@en
type
label
Tumor-specific methylation of ...... and other types of lymphomas.
@en
prefLabel
Tumor-specific methylation of ...... and other types of lymphomas.
@en
P2093
P356
P1433
P1476
Tumor-specific methylation of ...... l and other types of lymphomas
@en
P2093
Gopesh Srivastava
Jianming Ying
Kwan Yeung Lee
Paul Murray
Richard F Ambinder
Yajun Wang
Yun-Wen Chen
P356
10.4161/EPI.2.1.3883
P577
2007-01-15T00:00:00Z